CRL
- Charles River Laboratories International, Inc.
()
Overview
Company Summary
Charles River Laboratories International, Inc. (CRL) is a global company that provides essential products and services to support the drug discovery and development process for pharmaceutical, biotechnology, and academic clients. Founded in 1947, CRL is headquartered in Wilmington, Massachusetts.
CRL operates as a contract research organization (CRO), offering a wide range of preclinical and clinical laboratory services. These services primarily involve the testing of potential drugs and therapies in both animals and humans, enabling clients to gather critical data and make informed decisions during the drug development process.
The company's preclinical services include toxicology, drug safety assessment, genetic testing, pathology, and specialized research models. CRL is known for its expertise in conducting safety assessments to evaluate the potential risks and effects of drug compounds on different systems within the body.
Additionally, CRL offers a variety of clinical services, which involve conducting human clinical trials to test the safety and effectiveness of new drugs and treatments. These services encompass study design, project management, site monitoring, data collection, and analysis.
Beyond its laboratory services, CRL provides a comprehensive portfolio of research models and associated products to aid drug discovery and development. They offer genetically engineered models, surgical models, and a vast array of disease models, enabling scientists to better understand diseases, evaluate potential treatment options, and assess drug efficacy.
CRL aims to assist its clients in accelerating the drug development process by delivering high-quality data, expert scientific support, and a broad range of resources. By doing so, the company contributes to the advancement of pharmaceutical research, helping bring innovative therapies to market and improving patient health outcomes.